【摘要】目的 探讨乙肝核心抗体对于肾移植患者的影响。方法 观察不同乙肝标志物[A组(HBsAg+，HBcAb+)，B组(HBsAg-，HBcAb+),C组(HBsAg-，HBcAb-)]组间肾移植患者肝功能、肾功能等指标间的差异。 结果 A组肝功能异常发生率52.0%，B组肝功能异常发生率36.8%，C组肝功能异常发生率8.69%，三组间比较均有显著差异。 结论 肾移植患者合并单纯乙肝核心抗体阳性肝功能异常发生率仍较高.
【Abstract】 Objective To study the influence of anti-hepatitis B core antigen antibody (HBcAb) on renal transplantation patients. Methods Patients were divided into 3 groups based on the markers for hepatitis B virus infection: Group A (HBsAg+ and HBcAb+), Group B (HBsAg- and HBcAb+), and Group C (HBsAg- and HBcAb-). Liver damage and kidney function were analyzed among the 3 groups after renal transplantation. Results The incidence of liver damage was 52.0% in group A, 36.8% in group B, and 8.69% in group C. Significant differences were found among the 3 groups. Conclusions Liver damage is frequently seen in patients with positive HBcAb after transplantation.
PDF(173 KB)
